Cardiovascular Surgical Devices: Technologies and Global Markets

Published - Oct 2013| Analyst - Mary C. Patton| Code - HLC076B
Market Research Report Single User License: $2750 Member Price: FREE

Report Highlights

The global market for cardiovascular surgical devices was valued at $29.7 billion in 2012. This market is expected to reach nearly $31.7 billion in 2013 and nearly $47.2 billion by 2018, a compound annual growth rate (CAGR) of 8.3% for the period of 2013 to 2018.

Report Includes

  • An overview of the global market for cardiovascular surgical devices.
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) for the period 2013 to 2018.
  • Incidence rates of cardiovascular diseases in the United States, WHO regions, and in selected countries.
  • Discussion of key cardiovascular surgical procedures, traditional and interventional surgery, and adoption of robotics in surgery.
  • Examination of procedures related to cardiac rhythm management, including devices and definitions.
  • Reviews of procedures and devices related to cardiac assist.
  • Patent analysis of various devices by year and by assignee.
  • Comprehensive company profiles of major players in the industry.

SCOPE OF REPORT

The scope of this study encompasses multiple technologies and procedures related to cardiovascular surgical devices. The study focused primarily on four categories of cardiovascular surgery: traditional (open), interventional, cardiac rhythm management (CRM) and cardiac ablation procedures. These procedure categories are categorized logically so that comparisons can be made within procedural groups as well as across the cardiovascular surgical devices industry as a whole. Note that carotid artery surgery related to stroke, AAA surgery to correct aortic aneurysms, and surgical and stenting procedures designed to address peripheral vascular disease are not addressed in detail in this report.

BCC analyzes the industry on a worldwide basis from market, product and technology perspectives. Regulations and reimbursement issues and patents issued from 2010 through mid-2013 are also examined to identify patient safety, regulatory review and insurance coverage issues for stakeholders and potential stakeholders in this industry.

The report examines the cardiovascular surgery device industry in general, the types of technologies currently in use as well as future technological developments, and regulatory influences that affect product distribution. The industry structure section discussed the most active manufactures with respect to relative market share, marketing strengths and forces that promote or hinder the growth of technologies. The technology sections detail historical, current (2013) and projected (2013 to 2018) market values.

ANALYST CREDENTIALS

Mary C. Patton, M.B.A, D.B.A., is the BCC Research Analyst of this report. Dr. Patton’s experience includes over 25 years of designing and managing custom research projects involving both qualitative and quantitative techniques with a broad range of medical, surgical and healthcare industry providers and patients. She has conducted extensive research on surgical devices, diagnostic equipment, specific disease states, EMR systems and PACS systems. She has also worked in product management and strategic management roles for several major medical device manufacturers. Dr. Patton is the author of more than a dozen previous research reports related to the medical device industry.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Oct-2010| Analyst - Peggy Lehr| Code - HLC076A

Report Highlights

  • The global market for cardiovascular surgical devices used in the operating room is worth an estimated $31 billion in 2010. By 2015, this market will be valued at nearly $48 billion, a compound annual growth rate (CAGR) of 8.7%.
  • Despite significant growth in interventional cardiac surgery procedures, the traditional cardiac surgical device market is expected to expand faster, primarily driven by the growth in cardioprosthetics such as ventricular assist devices. This sector is worth an estimated $7 billion in 2010 and is expected to increase at a 10.9% compound annual growth rate (CAGR) to reach $12 billion in 2015.
  • The second fastest area of growth is in cardiac rhythm management devices, particularly for the treatment of atrial fibrillation (AF). This sector is valued at $11 billion in 2010 and is expected to be worth $18 billion in 2015, a compound annual growth rate (CAGR) of 10.2%.
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report